Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: A systematic review of randomized controlled trials

British Journal of Dermatology

Volumn 152, Issue 3, 2005, Pages 518-523

  Chen, Keng ^a   Craig, J C ^b   Shumack, S ^c  

^a ROYAL HOSPITAL HASLAR   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Acitretin; Basal cell carcinoma; Squamous cell carcinoma; Transplantation

Indexed keywords

ETRETIN; ETRETINATE; RETINOID;

ALOPECIA; BASAL CELL CARCINOMA; BOWEN DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; DESQUAMATION; DOSE RESPONSE; DRUG TOLERANCE; DRY EYE; DYSPHAGIA; EMBASE; EPISTAXIS; GASTRITIS; HEADACHE; HUMAN; HYPERLIPIDEMIA; LIVER TOXICITY; MEDLINE; META ANALYSIS; MUSCULOSKELETAL DISEASE; MYALGIA; NAIL DISEASE; ORGAN TRANSPLANTATION; PARONYCHIA; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

ACITRETIN; ADMINISTRATION, ORAL; HUMANS; ORGAN TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS; RETINOIDS; SKIN NEOPLASMS;

EID: 17444367310     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06347.x     Document Type: Review

References (11)

1. Bouwes Bavinck JN, Hardie DR, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61:715-21.
2. Ong CS, Keogh AM, Kossard S et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40:27-34.
3. Haagsma EB, Hagens VE, Schaapveld M et al. Increased cancer risk after liver transplantation: a population based study. J Hepatol 2001; 34:84-91.
4. Hartevelt MM, Bouwes Bavinck JN, Kootte AMM et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506-9.
5. Nguyen EQH, Wolverton SE. Systemic retinoids. In: Comprehensive Dermatologic Drug Therapy (Wolverton SE, ed.). Philadelphia: W.B. Saunders, 2001; 269-310.
6. Shuttleworth D, Marks R, Griffin PJA et al. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988; 68:717-24.
7. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999; 140:656-60.
8. Yuan Z, Davis A, Macdonald K, Bailey RR. Use of acitretin for the skin complications in renal transplant recipients. NZ Med J 1995; 108:255-6.
9. George R, Weightman W, Russ GR et al. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol 2002; 43:269-73.
10. Bouwes Bavinck JN, Tieben LM, van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind placebo controlled study. J Clin Oncol 1995; 13:1933-8.
11. de Sevaux RGL, Smit JV, de Jong EMGJ et al. Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomised trial comparing two doses of acitretin. J Am Acad Dermatol 2003; 49:407-12.